This isn't just a blip on the the radar, or a dastardly plot by the pharma industry to increase profits; it's an evolution of how drugs are used to treat patients. (Photo: Shutterstock)
Ask any employer and they'll tell you the same thing: pharmacy spending is eating up a bigger portion of their health care budgets, specialty drugs in particular. In fact, last year Cigna saw drugs and biologics comprise 26 percent of medical spending for Cigna, making it the top contributor to costs.
“That trend is expected to continue out into the future,” Cigna VP of value-based partnerships Thomas Stambaugh told attendees at a recent webinar hosted by EBRI. “We expect that by 2020, pharma will be 31 percent of our total cost.”
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Emily Payne
Emily Payne is director, content analytics for ALM's Business & Finance Markets and former managing editor for BenefitsPRO. A Wisconsin native, she has spent the past decade writing and editing for various athletic and fitness publications. She holds an English degree and Business certificate from the University of Wisconsin.
